mTORC1 Inhibitor Rapamycin Inhibits Growth of Cerebral Cavernous Malformation in Adult Mice
Stroke · 2023-11 · 54 (11) · 2906-2917
DOI: 10.1161/strokeaha.123.044108 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stroke, 2023-11. Verfasst von Lun Li und 16 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Institute and Department of Medicine, Perelman School of Medicine (L.L., A.A.R., S.G., J.Y., J.B., P.M.-I., J.G., M.L.K.), University …. Hauptthemen laut MEDLINE: Hemangioma, Cavernous, Central Nervous System. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, NHLBI NIH HHS, NIH HHS.
Abstract (Originalsprache)
BACKGROUND: Cerebral cavernous malformations (CCMs) are vascular malformations that frequently cause stroke. CCMs arise due to loss of function in one of the genes that encode the CCM complex, a negative regulator of MEKK3-KLF2/4 signaling in vascular endothelial cells. Gain-of-function mutations in PIK3CA (encoding the enzymatic subunit of the PI3K (phosphoinositide 3-kinase) pathway associated with cell growth) synergize with CCM gene loss-of-function to generate rapidly growing lesions. METHODS: We recently developed a model of CCM formation that closely reproduces key events in human CCM formation through inducible CCM loss-of-function and PIK3CA gain-of-function in mature mice. In the present study, we use this model to test the ability of rapamycin, a clinically approved inhibitor of the PI3K effector mTORC1, to treat rapidly growing CCMs. RESULTS: We show that both intraperitoneal and oral administration of rapamycin arrests CCM growth, reduces perilesional iron deposition, and improves vascular perfusion within CCMs. CONCLUSIONS: Our findings further establish this adult CCM model as a valuable preclinical model and support clinical testing of rapamycin to treat rapidly growing human CCMs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cardiovascular Institute and Department of Medicine, Perelman School of Medicine (L.L., A.A.R., S.G., J.Y., J.B., P.M.-I., J.G., M.L.K.), University of Pennsylvania, Philadelphia.
- Department of Neurosurgery, Perelman School of Medicine, Hospital of the University of Pennsylvania (L.L., Y.S.S., J.-K.B.), University of Pennsylvania, Philadelphia.
- Neurovascular Surgery Program, Section of Neurosurgery, Department of Surgery, The University of Chicago Medicine and Biological Sciences, IL (R.S., R.A., T.M., R.L., D.D., I.A.A.).
- Department of Molecular Genetics and Microbiology, School of Medicine, Duke University, Durham, NC (D.A.M.).
ORCID-Profile: Aileen A Ren, Siqi Gao, Patricia Mericko-Ishizuka, Joanna Griffin, Robert Shenkar, Roberto Alcazar, Rhonda Lightle, Dorothy DeBiasse, Issam A Awad, Douglas A Marchuk, Mark L Kahn, Jan-Karl Burkhardt
Förderung
- NINDS NIH HHS
- NHLBI NIH HHS
- NIH HHS
Zitieren
APA
Li, L., Ren, A. A., Gao, S., Su, Y. S., Yang, J., Bockman, J., Mericko-Ishizuka, P., Griffin, J., Shenkar, R., Alcazar, R., Moore, T., Lightle, R., DeBiasse, D., Awad, I. A., Marchuk, D. A., Kahn, M. L., & Burkhardt, J. K. (2023). mTORC1 Inhibitor Rapamycin Inhibits Growth of Cerebral Cavernous Malformation in Adult Mice. Stroke, 54(11), 2906-2917. https://doi.org/10.1161/strokeaha.123.044108
Vancouver
Li L, Ren AA, Gao S, Su YS, Yang J, Bockman J, et al. mTORC1 Inhibitor Rapamycin Inhibits Growth of Cerebral Cavernous Malformation in Adult Mice. Stroke. 2023;54(11):2906-2917. doi:10.1161/strokeaha.123.044108
BibTeX
@article{Li2023,
author = {Li, Lun and Ren, Aileen A and Gao, Siqi and Su, Yourong S and Yang, Jisheng and Bockman, Jenna and Mericko-Ishizuka, Patricia and Griffin, Joanna and Shenkar, Robert and Alcazar, Roberto and Moore, Thomas and Lightle, Rhonda and DeBiasse, Dorothy and Awad, Issam A and Marchuk, Douglas A and Kahn, Mark L and Burkhardt, Jan-Karl},
title = {mTORC1 Inhibitor Rapamycin Inhibits Growth of Cerebral Cavernous Malformation in Adult Mice},
journal = {Stroke},
year = {2023},
volume = {54},
number = {11},
pages = {2906--2917},
doi = {10.1161/strokeaha.123.044108}
}
EUVIMED